The expression levels of CD105 in the tumoral specimen seem to be more closely correlated with the expression of VEGF (in comparison to other endothelial biomarkers); thus, we can hypothesize that higher levels of CD105 in tumoral tissue would mean a better response to BEV as there would be more VEGF expressed within the tumor (9, 11). The gene discussed is ENG; the disease is neoplasm.